Stergios Tsartsalis

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

EXPRESS: Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout.

EXPRESS: Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 01, 2026

Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout.

Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 01, 2026

Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.

Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.

Journal: Acta neuropathologica

Published: February 20, 2026

Chemogenetic activation of oxytocinergic neurons rescues neural correlates of encephalopathy of prematurity in mice.

Chemogenetic activation of oxytocinergic neurons rescues neural correlates of encephalopathy of prematurity in mice.

Journal: Neurobiology of disease

Published: November 02, 2025

TSPO contributes to neuropathology and cognitive deficits in Alzheimer's disease.

TSPO contributes to neuropathology and cognitive deficits in Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: July 31, 2025

Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury.

Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury.

Journal: Brain, behavior, and immunity

Published: July 15, 2025

Corrigendum to "radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans" [nuclear medicine and biology, 144-145 (2025); 109,011].

Corrigendum to "radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans" [nuclear medicine and biology, 144-145 (2025); 109,011].

Journal: Nuclear medicine and biology

Published: June 25, 2025

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease.

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease.

Journal: Neurobiology of disease

Published: April 14, 2025

Severe Lithium Toxicity due to the Use of Unauthorized Weight Loss Medication.

Severe Lithium Toxicity due to the Use of Unauthorized Weight Loss Medication.

Journal: Bipolar disorders

Published: March 20, 2025

Early metabolic changes in the brain of Alzheimer's disease rats are driven by GLAST+ cells.

Early metabolic changes in the brain of Alzheimer's disease rats are driven by GLAST+ cells.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: February 07, 2025

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans.

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans.

Journal: Nuclear medicine and biology

Published: December 16, 2024

Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease.

Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease.

Journal: NeuroImage

Published: January 08, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026